M&T Bank Corp Deciphera Pharmaceuticals, Inc. Transaction History

M&T Bank Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$7.7 - $37.13 $52,267 - $252,038	-6,788 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$26.46 - $37.15 $52 - $74	-2 Reduced 0.03%	6,788 $230,000
Q1 2021 May 06, 2021	BUY	$40.39 - $56.73 $24,920 - $35,002	617 Added 10.0%	6,790 $305,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $4,555 - $5,823	88 Added 1.45%	6,173 $352,000
Q3 2020 Nov 06, 2020	BUY	$43.8 - $58.16 $53,173 - $70,606	1,214 Added 24.92%	6,085 $312,000
Q2 2020 Jul 29, 2020	BUY	$37.05 - $65.03 $180,470 - $316,761	4,871 New	4,871 $291,000
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $148,947 - $307,372	-4,429 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$31.7 - $69.93 $140,399 - $309,719	4,429 New	4,429 $276,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.